First Time Loading...

Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 13 USD -2.69% Market Closed
Updated: May 19, 2024

Verona Pharma PLC
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Pre-Tax Income Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Pre-Tax Income
-$53.9m
CAGR 3-Years
6%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Pre-Tax Income
£5.5B
CAGR 3-Years
-6%
CAGR 5-Years
2%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Pre-Tax Income
$7.4B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
11%
Indivior PLC
LSE:INDV
Pre-Tax Income
$6m
CAGR 3-Years
-56%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Pre-Tax Income
$281m
CAGR 3-Years
-20%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Pre-Tax Income
-£36.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Verona Pharma PLC's Pre-Tax Income?
Pre-Tax Income
-53.9m USD

Based on the financial report for Dec 31, 2023, Verona Pharma PLC's Pre-Tax Income amounts to -53.9m USD.

What is Verona Pharma PLC's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-11%

Over the last year, the Pre-Tax Income growth was 21%. The average annual Pre-Tax Income growth rates for Verona Pharma PLC have been 6% over the past three years , -11% over the past five years .